Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin

Circulation

Volumn 131, Issue 23, 2015, Pages 2032-2040

  Wildi, Karin ^a   Gimenez, Maria Rubini ^a,b   Twerenbold, Raphael ^a   Reichlin, Tobias ^a   Jaeger, Cedric ^a   Heinzelmann, Amely ^a   Arnold, Christiane ^c   Nelles, Berit ^a   Druey, Sophie ^a   Haaf, Philip ^a   Hillinger, Petra ^a   Schaerli, Nicolas ^a   Kreutzinger, Philipp ^a   Tanglay, Yunus ^a   Herrmann, Thomas ^a   Moreno Weidmann, Zoraida ^a   Krivoshei, Lian ^a   Freese, Michael ^a   Stelzig, Claudia ^a   Puelacher, Christian ^a   Rentsch, Katharina ^a   Osswald, Stefan ^a   Mueller, Christian ^a   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c KANTONSSPITAL   (Switzerland)

Author keywords

Acute cardiac care; Biological markers; Myocardial infarction; Troponin

Indexed keywords

TROPONIN; BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIAC TROPONIN 1 CLIA KIT; CLINICAL DECISION MAKING; CLINICAL DECISION VALUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ERROR; FEMALE; HEART INFARCTION; HUMAN; IMMUNOASSAY ANALYZER; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; UNSTABLE ANGINA PECTORIS; BLOOD; CLINICAL TRIAL; FOLLOW UP; HEART MUSCLE; INTERNATIONAL COOPERATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROSPECTIVE STUDIES; REFERENCE VALUES; SEX FACTORS; SURVIVAL RATE; TROPONIN I; TROPONIN T;

EID: 84936105484     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014129     Document Type: Article

References (36)

1. Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007;29: 1-32.
2. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127: E663-e828.
3. Hamm CW, Bassand JP, Agewall S, Bax JJ, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, ESC Committee for Practice Guidelines, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Document R, Achenbach S, Badimon L, Bertrand M, Botker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation. Eur Hear J. 2011;32: 2999-3054.
4. Brown TW, McCarthy ML, Kelen GD, Levy F. An epidemiologic study of closed emergency department malpractice claims in a national database of physician malpractice insurers. Acad Emerg Med. 2010;17: 553-560. doi: 10.1111/j.1553-2712.2010.00729.x.
5. McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, Patel A, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: A report from the Activate-SF registry. Arch Intern Med. 2012;172: 864-871. doi: 10.1001/archinternmed.2012.945.
6. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116: 2634-2653. doi: 10.1161/CIRCULATIONAHA.107.187397.
7. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Breidthardt T, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32: 1379-1389. doi: 10.1093/eurheartj/ehr033.
8. Koerbin G, Abhayaratna WP, Potter JM, Apple FS, Jaffe AS, Ravalico TH, Hickman PE. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin Biochem. 2013;46: 1636-1643. doi: 10.1016/j.clinbiochem.2013.08.004.
9. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, Huber K, Plebani M, Biasucci LM, Tubaro M, Collinson P, Venge P, Hasin Y, Galvani M, Koenig W, Hamm C, Alpert JS, Katus H, Jaffe AS; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33: 2252-2257. doi: 10.1093/eurheartj/ehs154.
10. Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin Chem. 2009;55: 5-8. doi: 10.1373/clinchem.2008.117218.
11. Paul M. McKie, Heublein DM, Scott CG, Gantzer M Lou, Ramila A. Mehta, Redfield RJRMM, Burnett JC Jr, Jaffe AS. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59: 1099-1107.
12. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med. 2012;50: 871-878. doi: 10.1515/cclm-2011-0540.
13. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58: 1574-1581. doi: 10.1373/clinchem.2012.192716.
14. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58: 219-225. doi: 10.1373/clinchem.2011.171082.
15. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Breidthardt T, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32: 1379-1389. doi: 10.1093/eurheartj/ehr033.
16. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361: 858-867. doi: 10.1056/NEJMoa0900428.
17. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124: 136-145. doi: 10.1161/CIRCULATIONAHA.111.023937.
18. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, Moehring B, Ziller R, Hoeller R, Rubini Gimenez M, Haaf P, Potocki M, Wildi K, Balmelli C, Freese M, Stelzig C, Freidank H, Osswald S, Mueller C. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172: 1211-1218. doi: 10.1001/archinternmed.2012.3698.
19. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, Aldous S, Meller B, Tate JR, Reichlin T, Hammett CJ, Zellweger C, Ungerer JP, Rubini Gimenez M, Troughton R, Murray K, Brown AF, Mueller M, George P, Mosimann T, Flaws DF, Reiter M, Lamanna A, Haaf P, Pemberton CJ, Richards AM, Chu K, Reid CM, Peacock WF, Jaffe AS, Florkowski C, Deely JM, Than M. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62: 1242-1249. doi: 10.1016/j.jacc.2013.02.078.
20. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem. 2009;55: 573-577. doi: 10.1373/clinchem.2008.116020.
21. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56: 254-261. doi: 10.1373/clinchem.2009.132654.
22. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, Giannitsis E, Gustafson S, Handy B, Katus H, Melanson SE, Panteghini M, Venge P, Zorn M, Jarolim P, Bruton D, Jarausch J, Jaffe AS. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412: 748-754. doi: 10.1016/j.cca.2010.12.034.
23. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361: 868-877. doi: 10.1056/NEJMoa0903515.
24. Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58: 54-61. doi: 10.1373/clinchem.2011.165795.
25. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145: 247-254.
26. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002;144: 981-986. doi: 10.1067/mhj.2002.124048.
27. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007;115: E352-e355. doi: 10.1161/CIRCULATIONAHA.107.182881.
28. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, Huber K, Plebani M, Biasucci LM, Tubaro M, Collinson P, Venge P, Hasin Y, Galvani M, Koenig W, Hamm C, Alpert JS, Katus H, Jaffe AS; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33: 2252-2257. doi: 10.1093/eurheartj/ehs154.
29. Vasile VC, Saenger AK, Kroning JM, Jaffe AS. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56: 1086-1090. doi: 10.1373/clinchem.2009.140616.
30. Wu AH, Lu QA, Todd J, Moecks J, Wians F. Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: Implications for clinical practice. Clin Chem. 2009;55: 52-58. doi: 10.1373/clinchem.2008.107391.
31. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem. 2009;55: 930-937. doi: 10.1373/clinchem.2008.114728.
32. Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, Zellweger C, Moehring B, Stallone F, Sou S, Mueller M, Denhaerynck K, Mosimann T, Reiter M, Freese M, Stelzig C, I K, Voegele J, Hartmann B, Rentsch K, Osswald S, Mueller C. Direct comparison of high-sensitivity cardiac troponin I versus T for the early diagnosis of acute myocardial infarction. Eur Hear J. 2014; 35: 2303-2311.
33. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012;126: 2020-2035.
34. Reichlin T, Twerenbold R, Reiter M, Steuer S, Bassetti S, Balmelli C, Winkler K, Kurz S, Stelzig C, Freese M, Drexler B, Haaf P, Zellweger C, Osswald S, Mueller C. Introduction of high-sensitivity troponin assays: Impact on myocardial infarction incidence and prognosis. Am J Med. 2012;125: 1205-1213.e1. doi: 10.1016/j.amjmed.2012.07.015.
35. Keller T, Ojeda F, Zeller T, Wild PS, Tzikas S, Sinning CR, Peetz D, Münzel T, Blankenberg S, Lackner KJ. Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay. Int J Cardiol. 2013;167: 1423-1429. doi: 10.1016/j. ijcard.2012.04.063.
36. Muhlestein JB, Anderson J, May H, Ilstrup SJ, Bach PR, Lappe D. A real world comparison between the Abbott troponin-I and the Roche troponin-T assays in the assessment of acute myocardial injury. J Am Coll Cardiol. 2013;61: E1155.